BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30

• Press Releases

  Atea Pharmaceuticals Announces Dosing of First Patient in C-BEYOND, Phase 3 Study Evaluating Regimen of Bemnifosbuvir and Ruzasvir for Treatment of Hepatitis C Virus

  April 9, 2025

   · 

  8 min read
• Press Releases

  Kymera Therapeutics Appoints Noah Goodman as Chief Business Officer

  April 9, 2025

   · 

  3 min read
• Press Releases

  Aclarion to Present at the Planet MicroCap Showcase: VEGAS in Partnership with MicroCapClub

  April 9, 2025

   · 

  2 min read
• Press Releases

  Cepheid and Oxford Nanopore Technologies Partner to Advance Automated Sequencing-Based Solutions

  April 9, 2025

   · 

  4 min read
• Press Releases

  ZEISS receives FDA clearance for INTRABEAM 700

  April 9, 2025

   · 

  6 min read
• Press Releases

  Solu Therapeutics Closes $41M Series A Financing and Announces First Patient Dosed in Phase 1 Clinical Trial of STX-0712 in Patients with CMML and Other Advanced Hematologic Malignancies

  April 9, 2025

   · 

  4 min read
• Press Releases

  Context Therapeutics Doses First Patient in Phase 1 Clinical Trial of CT-95

  April 9, 2025

   · 

  4 min read
• Press Releases

  Theratechnologies Reports Financial Results for the First Quarter 2025 and Reviews Key Achievements

  April 9, 2025

   · 

  24 min read
• Press Releases

  OS Therapies Completes Acquisition of Advaxis Immunotherapies Clinical, Pre-clinical and IP Assets from Ayala Pharmaceuticals

  April 9, 2025

   · 

  6 min read
• Press Releases

  Cingulate Receives $3 Million Grant from Private Foundation to Accelerate Development of Anxiety Asset CTx-2103 (buspirone)

  April 9, 2025

   · 

  6 min read